Literature DB >> 32699657

Optoelectronic Devices for Vision Restoration.

Victor Wang1, Ajay E Kuriyan2,3.   

Abstract

PURPOSE OF REVIEW: The goal is providing an update to the latest research surrounding optoelectronic devices, highlighting key studies and benefits and limitations of each device. RECENT
FINDINGS: The Argus II demonstrated long-term safety after five-year follow-up. Due to lack of tack fixation, subretinal implants appear to displace over time. PRIMA's completed primate trial showed initial safety and potential for improved vision, resulting in ongoing clinical trials Bionic Vision Australia developed a new 44-electrode suprachoroidal device currently in a clinical trial. Orion (cortical stimulation) is currently undergoing a clinical trial to demonstrate safety.
SUMMARY: Devices using external camera for images are unaffected by corneal or lens opacities but disconnect eye movements from image perception, while the opposite is true for implants directly detecting light. Visual acuity provided by devices is more complicated than implant electrode density and new devices aim to target this with innovative approaches.

Entities:  

Keywords:  Argus; Bionic Vision Australia; OptoEpiret; Optoelectronic devices; PRIMA; retinal implants

Year:  2020        PMID: 32699657      PMCID: PMC7375402          DOI: 10.1007/s40135-020-00232-2

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  35 in total

1.  Safety Studies for a 44-Channel Suprachoroidal Retinal Prosthesis: A Chronic Passive Study.

Authors:  Carla J Abbott; David A X Nayagam; Chi D Luu; Stephanie B Epp; Richard A Williams; Cesar M Salinas-LaRosa; Joel Villalobos; Ceara McGowan; Mohit N Shivdasani; Owen Burns; Jason Leavens; Jonathan Yeoh; Alice A Brandli; Patrick C Thien; Jenny Zhou; Helen Feng; Chris E Williams; Robert K Shepherd; Penelope J Allen
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

Review 2.  Attaining higher resolution visual prosthetics: a review of the factors and limitations.

Authors:  Calvin D Eiber; Nigel H Lovell; Gregg J Suaning
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

3.  Interim results from the international trial of Second Sight's visual prosthesis.

Authors:  Mark S Humayun; Jessy D Dorn; Lyndon da Cruz; Gislin Dagnelie; José-Alain Sahel; Paulo E Stanga; Artur V Cideciyan; Jacque L Duncan; Dean Eliott; Eugene Filley; Allen C Ho; Arturo Santos; Avinoam B Safran; Aries Arditi; Lucian V Del Priore; Robert J Greenberg
Journal:  Ophthalmology       Date:  2012-01-11       Impact factor: 12.079

Review 4.  Rehabilitation of lost functional vision with the Argus II retinal prosthesis.

Authors:  Michelle Markowitz; Mark Rankin; Mohamed Mongy; Beatrice E Patino; Joshua Manusow; Robert G Devenyi; Samuel N Markowitz
Journal:  Can J Ophthalmol       Date:  2018-01-12       Impact factor: 1.882

5.  Changes in microchip position after implantation of a subretinal vision prosthesis in humans.

Authors:  Laura Kuehlewein; Nicole Troelenberg; Krunoslav Stingl; Sebastian Schleehauf; Akos Kusnyerik; Timothy L Jackson; Robert E MacLaren; Caroline Chee; Johann Roider; Barbara Wilhelm; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl
Journal:  Acta Ophthalmol       Date:  2019-02-28       Impact factor: 3.761

6.  One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study.

Authors:  Kim Schaffrath; Hannah Schellhase; Peter Walter; Albert Augustin; Marzio Chizzolini; Bernd Kirchhof; Salvatore Grisanti; Peter Wiedemann; Peter Szurman; Gisbert Richard; Robert J Greenberg; Jessy D Dorn; Francesco Parmeggiani; Stanislao Rizzo
Journal:  JAMA Ophthalmol       Date:  2019-08-01       Impact factor: 7.389

7.  First-in-human trial of a novel suprachoroidal retinal prosthesis.

Authors:  Lauren N Ayton; Peter J Blamey; Robyn H Guymer; Chi D Luu; David A X Nayagam; Nicholas C Sinclair; Mohit N Shivdasani; Jonathan Yeoh; Mark F McCombe; Robert J Briggs; Nicholas L Opie; Joel Villalobos; Peter N Dimitrov; Mary Varsamidis; Matthew A Petoe; Chris D McCarthy; Janine G Walker; Nick Barnes; Anthony N Burkitt; Chris E Williams; Robert K Shepherd; Penelope J Allen
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

8.  The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience.

Authors:  Mohsen Farvardin; Mehrdad Afarid; Adel Attarzadeh; Mohammad K Johari; Morsal Mehryar; M Hossein Nowroozzadeh; Feisal Rahat; Hossein Peyvandi; Reza Farvardin; Mohammad Nami
Journal:  Front Neurosci       Date:  2018-09-05       Impact factor: 4.677

9.  Improved focalization of electrical microstimulation using microelectrode arrays: a modeling study.

Authors:  Sébastien Joucla; Blaise Yvert
Journal:  PLoS One       Date:  2009-03-12       Impact factor: 3.240

10.  Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa.

Authors:  Thomas L Edwards; Charles L Cottriall; Kanmin Xue; Matthew P Simunovic; James D Ramsden; Eberhart Zrenner; Robert E MacLaren
Journal:  Ophthalmology       Date:  2017-10-27       Impact factor: 12.079

View more
  2 in total

Review 1.  Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies.

Authors:  Alessandro Abbouda; Filippo Avogaro; Mariya Moosajee; Enzo Maria Vingolo
Journal:  Medicina (Kaunas)       Date:  2021-01-12       Impact factor: 2.430

Review 2.  Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.

Authors:  Malena Daich Varela; Thales Antonio Cabral de Guimaraes; Michalis Georgiou; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2021-03-12       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.